Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.40    -3.20 (-1.58%)
Bid:
199.10
Ask:
199.70
Spread: 0.60 (0.301%)
Market Cap: £1.30b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Apr 2019 07:00

RNS Number : 2630W
Ashmore Group PLC
16 April 2019
 

Ashmore Group plc16 April 2019

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 March 2019.

Assets under management

Theme

Actual31 December 2018

(US$ billion)

Estimated31 March 2019

(US$ billion)

Movement

(%)

External debt

15.5

16.7

+7.7%

Local currency

17.5

19.1

+9.1%

Corporate debt

10.8

14.1

+30.6%

Blended debt

20.4

22.0

+7.8%

Equities

4.4

4.7

+6.8%

Alternatives

1.6

1.6

-

Multi-asset

0.4

0.5

+25.0%

Overlay / liquidity

6.1

6.6

+8.2%

Total

76.7

85.3

+11.2%

 

Assets under management increased by US$8.6 billion during the period, through net inflows of US$5.0 billion and positive investment performance of US$3.6 billion.

Client demand remains strong and broad-based across investment themes, with net inflows in the corporate debt, local currency, overlay/liquidity, blended debt and external debt investment themes. Institutional flows continue to be biased towards existing clients, including additional allocations to large mandates in the corporate debt and overlay/liquidity themes. There was ongoing momentum in mutual fund flows, particularly in Europe and the US, with continued interest in the short duration, local currency bond and blended debt strategies.

Absolute performance levels were highest in the blended debt and external debt themes, and despite US dollar strength in the latter part of the period, local currency and equities delivered good returns over the three months. Corporate debt and multi-asset also produced positive performance. Ashmore's relative investment performance remains strong over three and five years, and the consistent implementation of its investment processes means that one year performance versus benchmarks has, as expected, improved strongly over the quarter.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Client activity levels picked up through the quarter following a slight pause at the end of 2018. This reflects a number of ongoing positive factors including investors' light positioning in Emerging Markets, the significant value available across a diverse range of investment themes, and slowing growth and political challenges in the developed world. The increasing diversity of Ashmore's product range enables flows to be captured at different points in the cycle. These factors, together with the delivery of strong performance across the investment themes, mean Ashmore is well-positioned for continued growth."

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)20 3727 1141Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSRSSIELIA
Date   Source Headline
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.